Comparability is important for evaluating changes in manufacturing and biosimilars. It's a flexible approach that recognizes biologicals can vary and minor quality differences may not matter clinically. The rules for comparability have been strong for 20 years, but now there's a need to make them clearer and better for biosimilar applications. A more careful and solid approach to comparability is possible and helpful.